CROS NT Ltd Announces Acquisition of MDSL International Ltd. - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
CROS NT Ltd Announces Acquisition of MDSL International Ltd.

Source: Applied Clinical Trials

CROS NT Ltd, the UK branch of CROS NT, announced the acquisition of MDSL International, a clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistics. In addition to adding resources for the CROS NT UK location, it also provides a new headquarters, located in Maidenhead, near London.

The financial details of the transaction remain confidential.

You can read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
7%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here